Document is current
Any future updates will be listed below
-
Authors
Ding, Chenyue
Zou, Qinyan
Wang, Fuxin
Wu, Huihua
Chen, Rulei
Lv, Jinghuan
Ling, Mingfa
Sun, Jian
Wang, Wei
Li, Hong
Huang, Boxian
-
Funding
Funding for this research was provided by:
Suzhou science and technology for people's livelihood (SYS201771)
Suzhou key medicine center (SZZX201505)
Suzhou Health Bureau fund (lczx201411)
Maternal and health care project of Jiangsu Province- assisted reproduction medicine center (FKX201224)
Jiangsu Provincial medical innovation team (CXTDB2017013)
Project funded by China Postdoctoral Science Fundation (2017M611871)
Suzhou introduce expert team of clinical medicine (SZYJTD201708)
- License Information
-
More Information
Article History
Received: 25 July 2017
Revised: 12 December 2017
Accepted: 16 January 2018
First Online: 9 March 2018
Ethics approval and consent to participate
: The use of human ovarian granular cells and human peripheral blood mononuclear cells were in accordance with the relevant guidelines and regulations, and the experimental protocols were approved by the Medical Ethics Committee of the Suzhou Hospital Affiliated to Nanjing Medical University (NJMU-2015-014). All the patients provided written informed consent prior to participation in this study.Our investigation using experimental animals was conducted on the basis of the Nanjing Medical University Animal Center’s specific guidelines and standards.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
